2Russell P J, Pomley J, Raghavan D. The use of monoclonal antibodies for thediagnosis and therapy of bladder cancer. Br J Urol,1993,71:121～125
3Zimmern P E, Laub D, Leach G E. Fluorescein angiography of the bladder:techniqueand relevance to bladder cancer and interstitial cystitis patients. J Urol,1995,154:62～65
4Kriegmair M,Baumgartner R, Knuechel R, et al. Detection of early bladder cancer by5-aminolae-vulinic acid induced porphyrin fluorescence. J Urol,1996,155:105～109
5Wheeless L L,Badalament R A,deVere White,et al.Consensus review of the clinicalutility of DNA cytometry in bladder cancer. Report of the DNA cytometry consensusconference. Cytometry,1993,14:478～481
6Planz B,Striepecke E,Jakse G, et al. Use of lewis X antigen and dexyribonucleic andimage cytometry to increase sensitivity of urinary cytology in transitional cell carcinomaof the bladder. J Urol,1998,159:384～387
7Ramakumar S, Bhuiyan J ,Besse J A, et al. Comparison of screening methods in thedetection of bladder cancer. J Urol,1999,161:388～394
8Zhang C L, Yu L Z, Ge F L, et al. Targeted diagnosis of bladder and ureteralcarcinoma using radiolabelled BDI-1. Urol Res,1998,26:343～348
9D′Hallewin M A, Baert L. Initial evaluation of the bladder tumor antigen test insuperficial bladder cancer. J Urol,1996,155:475～476
10Johnston B, Morales A, Emerson L,et al. Rapid detection of bladder cancer:acompararive study of point of care tests. J Urol,1997,158:2098～2101
